This NDC is on FDA's drug shortage list (posted Nov 3, 2023)
Reported reason: Other
Product Information
CROMOLYN 100 MG/5 ML ORAL CONC is a generic product labeled by Ritedose Pharmaceuticals, LLC, priced at $0.3490 per ML under NDC 76204002596. Its NADAC has been published 174 times since Sep 28, 2022.
FDA first approved this application on Oct 16, 2017. Its Orange Book therapeutic-equivalence code is AA.
Strength
100 mg/5mL
Manufacturer
Ritedose Pharmaceuticals, LLCNDC
76204002596
Classification
Generic
Dosage Form
SOLUTION, CONCENTRATE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CROMOLYN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA209264FDA Approved
10/16/2017
TE Code
AA
On Market Since
12/1/2021
Pharmacological Classes
Price Statistics
The NADAC for CROMOLYN 100 MG/5 ML ORAL CONC has been published 174 times since Sep 28, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3490 per ML |
|---|---|
| All-time high | $0.4825 (Mar 13, 2024) |
| All-time low | $0.1665 (Nov 20, 2024) |
| 52-week high | $0.3490 |
| 52-week low | $0.3141 |
| Median price | $0.3173 |
| Average price | $0.3183 |
| Largest weekly change | +85.7% (Jan 17, 2024) |
| Weeks tracked | 174 |
| Tracking since | Sep 28, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Cromolyn Sodium Oral Solution (Concentrate) market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ritedose Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cromolyn Sodium Oral Solution (Concentrate) market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Mast Cell Stabilizer class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CROMOLYN 100 MG/5 ML ORAL CONC?
The current National Average Drug Acquisition Cost (NADAC) for CROMOLYN 100 MG/5 ML ORAL CONC, manufactured by Ritedose Pharmaceuticals, LLC, is $0.3490 per ML (NDC 76204002596), effective Sep 30, 2026.
How has the price of CROMOLYN 100 MG/5 ML ORAL CONC changed over time?
Over the history we have for it, the NADAC for CROMOLYN 100 MG/5 ML ORAL CONC has held within roughly two percent of its current level. It has been tracked across 174 weekly CMS publications since Sep 28, 2022.
What are the highest and lowest recorded NADAC prices for CROMOLYN 100 MG/5 ML ORAL CONC?
Since Sep 28, 2022, the NADAC for CROMOLYN 100 MG/5 ML ORAL CONC has ranged from a low of $0.1665 (Nov 20, 2024) to a high of $0.4825 (Mar 13, 2024), with a median of $0.3173 per ML.
Are there cheaper alternatives to CROMOLYN 100 MG/5 ML ORAL CONC?
No other NADAC-published product currently shares the active ingredient and strength of CROMOLYN 100 MG/5 ML ORAL CONC in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CROMOLYN 100 MG/5 ML ORAL CONC?
CROMOLYN 100 MG/5 ML ORAL CONC (NDC 76204002596) is labeled by Ritedose Pharmaceuticals, LLC, and CMS classifies it as a generic product.
Is CROMOLYN 100 MG/5 ML ORAL CONC in shortage?
Yes — NDC 76204002596 is currently listed in FDA's drug shortage database (posted Nov 3, 2023). Reported reason: Other.